Edition:
India

Masimo Corp (MASI.OQ)

MASI.OQ on NASDAQ Stock Exchange Global Select Market

89.26USD
8:56pm IST
Change (% chg)

$0.42 (+0.47%)
Prev Close
$88.84
Open
$88.81
Day's High
$89.53
Day's Low
$88.53
Volume
27,433
Avg. Vol
195,880
52-wk High
$104.71
52-wk Low
$80.72

Chart for

About

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings... (more)

Overall

Beta: 0.95
Market Cap(Mil.): $4,586.86
Shares Outstanding(Mil.): 51.64
Dividend: --
Yield (%): --

Financials

BRIEF-Masimo Announces CE Marking Of Rad-97 Pulse CO-Oximeter With Integrated NomoLine Capnography

* MASIMO ANNOUNCES CE MARKING OF RAD-97™ PULSE CO-OXIMETER® WITH INTEGRATED NOMOLINE™ CAPNOGRAPHY

10 Apr 2018

BRIEF-Masimo Corp Q4 GAAP Earnings Per Share $0.01

* QTRLY ‍TOTAL REVENUE, INCLUDING ROYALTY AND OTHER REVENUE, INCREASED 22.9% TO $225.2 MILLION​ Source text for Eikon: Further company coverage:

28 Feb 2018

BRIEF-Masimo Corp‍ Announced FDA Clearance Of Next Generation Sedline Brain Function Monitoring​

* MASIMO CORP - ‍ ANNOUNCED FDA CLEARANCE OF NEXT GENERATION SEDLINE BRAIN FUNCTION MONITORING​ Source text for Eikon: Further company coverage:

29 Jan 2018

BRIEF-Masimo Announces FDA Clearance For Home Use Of Rad-97

* MASIMO ANNOUNCES FDA CLEARANCE FOR HOME USE OF RAD-97™ Source text for Eikon: Further company coverage:

09 Jan 2018

BRIEF-Masimo ‍announces FDA clearance and U.S. release Of full family of NomoLine capnography sampling lines​

* ‍ANNOUNCES FDA CLEARANCE AND U.S. RELEASE OF FULL FAMILY OF NOMOLINE CAPNOGRAPHY SAMPLING LINES​ Source text for Eikon: Further company coverage:

27 Nov 2017

Earnings vs. Estimates